Ticker Scorecard - PLRX Basics Company: Pliant Therapeutics, Inc. IPO Date: June 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $187.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.60 | 3.07% Avg Daily Range (30 D): $0.41 | 4.39% Avg Daily Range (90 D): $0.39 | 3.32% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): 2.01M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 160 Avg Trade Size (Sh.) (90 D): 112 Institutional Trades Total Inst.Trades: 1,059 Avg Inst. Trade: $1.49M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.25M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $.75M Avg Closing Trade (90 D): $.89M Avg Closing Volume: 87.28K     News Feb 7, 2025 @ 9:58 PM Pliant Therapeutics Provides Update on BEACON-IPF,... Source: N/A Nov 18, 2024 @ 11:00 PM Pliant Therapeutics Presents Data from its Bexoteg... Source: N/A Jul 13, 2024 @ 1:35 AM Pliant Therapeutics CBO sells shares worth over $1... Source: Investing.Com May 7, 2024 @ 3:53 PM These Analysts Revise Their Forecasts On Pliant Th... Source: Avi Kapoor Mar 7, 2024 @ 3:00 PM Earnings Preview: Pliant Therapeutics, Inc. (PLRX)... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.34 $-.95 $-.92 Diluted EPS $-3.34 $-.95 $-.92 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -201.68M $ -57.76M $ -55.85M Operating Income / Loss $ -222.08M $ -62.01M $ -60.64M Cost of Revenue $ $ $ Net Cash Flow $ 23.42M $ -.77M $ -33.91M PE Ratio